Fig. 2From: Association of circulating proprotein convertase subtilisin/kexin type 9 concentration, prothrombin time and cardiovascular outcomes: a prospective cohort studyKaplan-Meier analysis according to different PCSK9, PT levels and the combination of PCSK9 and PT status. PCSK9, proprotein convertase subtilisin/kexin type 9; PT, prothrombin timeBack to article page